sulpiride has been researched along with Heart Failure in 3 studies
Sulpiride: A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed)
sulpiride : A member of the class of benzamides obtained from formal condensation between the carboxy group of 2-methoxy-5-sulfamoylbenzoic acid and the primary amino group of (1-ethylpyrrolidin-2-yl)methylamine.
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Under double-blind conditions, 150 mg of ibopamine (di-isobutyric ester of N-methyldopamine) or placebo were given orally to 11 patients with congestive heart failure; after 3 hours, 50 mg of sulpiride were administered intramuscularly." | 9.06 | Peripheral hemodynamic effects of ibopamine in patients with congestive heart failure. A placebo-controlled, double-blind study. ( Aggio, S; Ansani, L; Baracca, E; Ghirardi, P; Longhini, C; Musacci, GF; Toselli, T, 1989) |
| "Under double-blind conditions, 150 mg of ibopamine (di-isobutyric ester of N-methyldopamine) or placebo were given orally to 11 patients with congestive heart failure; after 3 hours, 50 mg of sulpiride were administered intramuscularly." | 5.06 | Peripheral hemodynamic effects of ibopamine in patients with congestive heart failure. A placebo-controlled, double-blind study. ( Aggio, S; Ansani, L; Baracca, E; Ghirardi, P; Longhini, C; Musacci, GF; Toselli, T, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saporito, F | 1 |
| Andò, G | 1 |
| Di Bella, G | 1 |
| Oreto, G | 1 |
| Fennell, WH | 1 |
| Taylor, AA | 1 |
| Young, JB | 1 |
| Brandon, TA | 1 |
| Ginos, JZ | 1 |
| Goldberg, LI | 1 |
| Mitchell, JR | 1 |
| Longhini, C | 1 |
| Ansani, L | 1 |
| Musacci, GF | 1 |
| Aggio, S | 1 |
| Baracca, E | 1 |
| Toselli, T | 1 |
| Ghirardi, P | 1 |
1 trial available for sulpiride and Heart Failure
| Article | Year |
|---|---|
Peripheral hemodynamic effects of ibopamine in patients with congestive heart failure. A placebo-controlled, double-blind study.
Topics: Aged; Aged, 80 and over; Deoxyepinephrine; Double-Blind Method; Female; Heart Failure; Heart Rate; H | 1989 |
2 other studies available for sulpiride and Heart Failure
| Article | Year |
|---|---|
Acute heart failure due to pheochromocytoma crisis after levosulpiride administration.
Topics: Acute Disease; Adrenal Gland Neoplasms; Adult; Heart Failure; Humans; Male; Pheochromocytoma; Sulpir | 2014 |
Propylbutyldopamine: hemodynamic effects in conscious dogs, normal human volunteers and patients with heart failure.
Topics: Adult; Aged; Animals; Blood Pressure; Dogs; Dopamine; Female; Heart Failure; Heart Rate; Hemodynamic | 1983 |